Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DMRA

Damora Therapeutics Inc

May 29 • 04:00PM ET

24.88

+0.04 0.16 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RYTM KYMR NUVL BMRN INCY KRYS VKTX AXSM MDGL NBIX

| Held by: VXF XBI FFSM ONEQ LABU JDOC WCEO PWS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.46	Insider Own	25.89%	Shs Outstand	60.30M	Perf Week	0.08%
Market Cap	1.53B	Forward P/E	-	EPS next Y	-2.20	Insider Trans	-0.01%	Shs Float	45.63M	Perf Month	3.97%
Enterprise Value	1.69B	PEG	-	EPS next Q	-0.44	Inst Own	74.12%	Short Float	2.83%	Perf Quarter	-15.89%
Income	-30.67M	P/S	-	EPS this Y	52.26%	Inst Trans	172.29%	Short Ratio	4.43	Perf Half Y	50.06%
Sales	0.00M	P/B	3.96	EPS next Y	-15.86%	ROA	-151.15%	Short Interest	1.29M	Perf YTD	8.13%
Book/sh	6.29	P/C	5.94	EPS next 5Y	13.65%	ROE	-165.55%	52W High	38.33 -35.08%	Perf Year	672.67%
Cash/sh	4.19	P/FCF	-	EPS past 3/5Y	-36.14% -34.72%	ROIC	-97.78%	52W Low	2.45 915.51%	Perf 3Y	-55.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.70% 6.63%	Perf 5Y	-81.26%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	77.59%	Oper. Margin	-	ATR (14)	1.69	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.98	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.67	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.98	EPS Q/Q	57.77%	SMA20	0.70%	Beta	1.47	Target Price	43.14
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-0.01%	Rel Volume	2.91	Prev Close	24.84
Employees	7	LT Debt/Eq	0.01	Earnings	May 12 AMC	SMA200	30.08%	Avg Volume	291.10K	Price	24.88
IPO	Oct 29, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	-59.88% -	Trades		Volume	846,725	Change	0.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)